The Journal of Clinical and Aesthetic Dermatology
Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis
Info
The Journal of Clinical and Aesthetic Dermatology
Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis
Dec 01, 2021
JCAD

Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis. 

Share